March 1, 2019

Mitsubishi Tanabe Pharma America Appoints Sam Shum as Vice President of Operations and Strategy

JERSEY CITY, N.J., March 1, 2019 – Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the promotion of Sam Shum to its executive leadership team as Vice President of Operations and Strategy. In this role, he will oversee the company’s operational function areas, including Finance, Supply Chain, Quality Assurance, Public Affairs, Patient Engagement and Business Process & Strategy.

“Sam has repeatedly demonstrated a conscientious, thoughtful approach to his work and is a key contributor to the MTPA success story,” said Atsushi Fujimoto, President, MTPA. “He brings strong capabilities in the financial policy, accounting and reporting functions for our Commercial business operations. Sam has always gone above and beyond, proving himself to be a collaborative leader.”

Previously Senior Director of Financial Planning and Analytics for MTPA, Sam will take on the VP position previously held by Armand Famiglietti, who plans to serve as a senior strategic advisor for the organization.

Sam has over 20 years of experience in the life sciences sector, having held various financial, operational and engineering positions at Purdue Pharma, OSi Specialties, CES and IBM. Prior to joining MTPA, he was Treasurer of Brookdale University Hospital and Medical Center in Brooklyn, NY, where he provided executive oversight for the hospital’s pharmacies,revenue cycle, procurement, accounting operations and treasury management, and served as the liaison to the New York State Department of Health.

About Mitsubishi Tanabe Pharma America, Inc.
Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation’s (MTPC) 100 percent owned U.S. holding company, Mitsubishi Tanabe Pharma Holdings America, Inc. MTPA is dedicated to delivering innovative products that address the unmet medical needs of patients in North America. It was established by MTPC to commercialize approved pharmaceutical products in North America with plans to expand its product line through collaborations with partners. For more information, please visit or follow us on Twitter and Facebook.

Media inquiries:
Debbie Etchison